Cargando…

Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, but relevant data for older individuals are sparse. We analysed data from the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study of 5804 participants aged 70–82 years with a history...

Descripción completa

Detalles Bibliográficos
Autores principales: Poortvliet, Rosalinde K. E., Ford, Ian, Lloyd, Suzanne M., Sattar, Naveed, Mooijaart, Simon P., de Craen, Anton J. M., Westendorp, Rudi G. J., Jukema, J. Wouter, Packard, Christopher J., Gussekloo, Jacobijn, de Ruijter, Wouter, Stott, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527505/
https://www.ncbi.nlm.nih.gov/pubmed/23285043
http://dx.doi.org/10.1371/journal.pone.0052438
_version_ 1782253738072735744
author Poortvliet, Rosalinde K. E.
Ford, Ian
Lloyd, Suzanne M.
Sattar, Naveed
Mooijaart, Simon P.
de Craen, Anton J. M.
Westendorp, Rudi G. J.
Jukema, J. Wouter
Packard, Christopher J.
Gussekloo, Jacobijn
de Ruijter, Wouter
Stott, David J.
author_facet Poortvliet, Rosalinde K. E.
Ford, Ian
Lloyd, Suzanne M.
Sattar, Naveed
Mooijaart, Simon P.
de Craen, Anton J. M.
Westendorp, Rudi G. J.
Jukema, J. Wouter
Packard, Christopher J.
Gussekloo, Jacobijn
de Ruijter, Wouter
Stott, David J.
author_sort Poortvliet, Rosalinde K. E.
collection PubMed
description Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, but relevant data for older individuals are sparse. We analysed data from the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study of 5804 participants aged 70–82 years with a history of, or risk factors for cardiovascular disease. Visit-to-visit variability in blood pressure (standard deviation) was determined using a minimum of five measurements over 1 year; an inception cohort of 4819 subjects had subsequent in-trial 3 years follow-up; longer-term follow-up (mean 7.1 years) was available for 1808 subjects. Higher systolic blood pressure variability independently predicted long-term follow-up vascular and total mortality (hazard ratio per 5 mmHg increase in standard deviation of systolic blood pressure = 1.2, 95% confidence interval 1.1–1.4; hazard ratio 1.1, 95% confidence interval 1.1–1.2, respectively). Variability in diastolic blood pressure associated with increased risk for coronary events (hazard ratio 1.5, 95% confidence interval 1.2–1.8 for each 5 mmHg increase), heart failure hospitalisation (hazard ratio 1.4, 95% confidence interval 1.1–1.8) and vascular (hazard ratio 1.4, 95% confidence interval 1.1–1.7) and total mortality (hazard ratio 1.3, 95% confidence interval 1.1–1.5), all in long-term follow-up. Pulse pressure variability was associated with increased stroke risk (hazard ratio 1.2, 95% confidence interval 1.0–1.4 for each 5 mmHg increase), vascular mortality (hazard ratio 1.2, 95% confidence interval 1.0–1.3) and total mortality (hazard ratio 1.1, 95% confidence interval 1.0–1.2), all in long-term follow-up. All associations were independent of respective mean blood pressure levels, age, gender, in-trial treatment group (pravastatin or placebo) and prior vascular disease and cardiovascular disease risk factors. Our observations suggest variability in diastolic blood pressure is more strongly associated with vascular or total mortality than is systolic pressure variability in older high-risk subjects.
format Online
Article
Text
id pubmed-3527505
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35275052013-01-02 Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) Poortvliet, Rosalinde K. E. Ford, Ian Lloyd, Suzanne M. Sattar, Naveed Mooijaart, Simon P. de Craen, Anton J. M. Westendorp, Rudi G. J. Jukema, J. Wouter Packard, Christopher J. Gussekloo, Jacobijn de Ruijter, Wouter Stott, David J. PLoS One Research Article Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, but relevant data for older individuals are sparse. We analysed data from the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study of 5804 participants aged 70–82 years with a history of, or risk factors for cardiovascular disease. Visit-to-visit variability in blood pressure (standard deviation) was determined using a minimum of five measurements over 1 year; an inception cohort of 4819 subjects had subsequent in-trial 3 years follow-up; longer-term follow-up (mean 7.1 years) was available for 1808 subjects. Higher systolic blood pressure variability independently predicted long-term follow-up vascular and total mortality (hazard ratio per 5 mmHg increase in standard deviation of systolic blood pressure = 1.2, 95% confidence interval 1.1–1.4; hazard ratio 1.1, 95% confidence interval 1.1–1.2, respectively). Variability in diastolic blood pressure associated with increased risk for coronary events (hazard ratio 1.5, 95% confidence interval 1.2–1.8 for each 5 mmHg increase), heart failure hospitalisation (hazard ratio 1.4, 95% confidence interval 1.1–1.8) and vascular (hazard ratio 1.4, 95% confidence interval 1.1–1.7) and total mortality (hazard ratio 1.3, 95% confidence interval 1.1–1.5), all in long-term follow-up. Pulse pressure variability was associated with increased stroke risk (hazard ratio 1.2, 95% confidence interval 1.0–1.4 for each 5 mmHg increase), vascular mortality (hazard ratio 1.2, 95% confidence interval 1.0–1.3) and total mortality (hazard ratio 1.1, 95% confidence interval 1.0–1.2), all in long-term follow-up. All associations were independent of respective mean blood pressure levels, age, gender, in-trial treatment group (pravastatin or placebo) and prior vascular disease and cardiovascular disease risk factors. Our observations suggest variability in diastolic blood pressure is more strongly associated with vascular or total mortality than is systolic pressure variability in older high-risk subjects. Public Library of Science 2012-12-20 /pmc/articles/PMC3527505/ /pubmed/23285043 http://dx.doi.org/10.1371/journal.pone.0052438 Text en © 2012 Poortvliet et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Poortvliet, Rosalinde K. E.
Ford, Ian
Lloyd, Suzanne M.
Sattar, Naveed
Mooijaart, Simon P.
de Craen, Anton J. M.
Westendorp, Rudi G. J.
Jukema, J. Wouter
Packard, Christopher J.
Gussekloo, Jacobijn
de Ruijter, Wouter
Stott, David J.
Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
title Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
title_full Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
title_fullStr Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
title_full_unstemmed Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
title_short Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
title_sort blood pressure variability and cardiovascular risk in the prospective study of pravastatin in the elderly at risk (prosper)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527505/
https://www.ncbi.nlm.nih.gov/pubmed/23285043
http://dx.doi.org/10.1371/journal.pone.0052438
work_keys_str_mv AT poortvlietrosalindeke bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT fordian bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT lloydsuzannem bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT sattarnaveed bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT mooijaartsimonp bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT decraenantonjm bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT westendorprudigj bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT jukemajwouter bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT packardchristopherj bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT gussekloojacobijn bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT deruijterwouter bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper
AT stottdavidj bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper